BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33165892)

  • 1. Histopathological prognostic factors for colorectal liver metastases: A systematic review and meta-analysis of observational studies.
    de Oliveira CVC; Fonseca GM; Kruger JAP; de Mello ES; Coelho FF; Herman P
    Histol Histopathol; 2021 Feb; 36(2):159-181. PubMed ID: 33165892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done?
    Knijn N; de Ridder JA; Punt CJ; de Wilt JH; Nagtegaal ID
    Histopathology; 2013 Aug; 63(2):149-56. PubMed ID: 23763641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases.
    Fonseca GM; de Mello ES; Faraj SF; Kruger JAP; Coelho FF; Jeismann VB; Lupinacci RM; Cecconello I; Alves VAF; Pawlik TM; Herman P
    J Surg Oncol; 2018 Jun; 117(7):1364-1375. PubMed ID: 29448312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumoral and Parenchymal Morphological Assessment in Liver Metastases of Colorectal Carcinoma: Micrometastasis, Peritumoral Lymphocytes, Tumor Budding and Differentiation are Potential Prognostic Factors.
    Aysal A; Agalar C; Egeli T; Ozbilgin M; Unek T; Somali I; Oztop I; Obuz F; Astarcioglu I; Sagol O
    Int J Surg Pathol; 2022 Dec; 30(8):861-871. PubMed ID: 35491669
    [No Abstract]   [Full Text] [Related]  

  • 6. Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
    Stift J; Graf A; Schwarz C; Tamandl D; Starlinger P; Herac M; Beer A; Wrba F; Bodingbauer M; Kaczirek K; Stremitzer S
    Eur J Surg Oncol; 2018 Jan; 44(1):139-147. PubMed ID: 29203074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological factors versus margin size in single colorectal liver metastases: Does a 1-cm margin size matter?
    Fonseca GM; de Mello ES; Faraj SF; Kruger JAP; Jeismann VB; Coelho FF; Alves VAF; Herman P
    Scand J Surg; 2022; 111(1):14574969211069329. PubMed ID: 35188005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: A systematic review and meta-analysis.
    Liu W; Wang HW; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Aug; 45(8):1349-1356. PubMed ID: 31054852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
    Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
    Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases.
    Wang XY; Zhang R; Wang Z; Geng Y; Lin J; Ma K; Zuo JL; Lu L; Zhang JB; Zhu WW; Chen JH
    Br J Surg; 2019 Dec; 106(13):1747-1760. PubMed ID: 31386192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases.
    Connor AA; McNamara K; Al-Sukhni E; Diskin J; Chan D; Ash C; Lowes LE; Allan AL; Zogopoulos G; Moulton CA; Gallinger S
    Ann Surg Oncol; 2016 Jul; 23(7):2168-75. PubMed ID: 26714949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
    Falcão D; Alexandrino H; Caetano Oliveira R; Martins J; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Cipriano MA; Castro E Sousa F
    Eur J Surg Oncol; 2018 Aug; 44(8):1212-1219. PubMed ID: 29691114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
    Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Postoperative Complications on Survival and Recurrence After Resection of Colorectal Liver Metastases: Systematic Review and Meta-analysis.
    Dorcaratto D; Mazzinari G; Fernandez M; Muñoz E; Garcés-Albir M; Ortega J; Sabater L
    Ann Surg; 2019 Dec; 270(6):1018-1027. PubMed ID: 30829704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol.
    Fonseca GM; Herman P; Faraj SF; Kruger JAP; Coelho FF; Jeismann VB; Cecconello I; Alves VAF; Pawlik TM; de Mello ES
    Histopathology; 2018 Feb; 72(3):377-390. PubMed ID: 28858385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological investigation of colon liver metastases - which factors affect survival after surgery?
    Torén W; Sasor A; Ansari D; Andersson R
    Scand J Gastroenterol; 2023 Jun; 58(6):627-633. PubMed ID: 36440692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
    Adam R; Bhangui P; Poston G; Mirza D; Nuzzo G; Barroso E; Ijzermans J; Hubert C; Ruers T; Capussotti L; Ouellet JF; Laurent C; Cugat E; Colombo PE; Milicevic M
    Ann Surg; 2010 Nov; 252(5):774-87. PubMed ID: 21037433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
    Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE
    Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.
    Mei Z; Liu Y; Liu C; Cui A; Liang Z; Wang G; Peng H; Cui L; Li C
    Br J Cancer; 2014 Mar; 110(6):1595-605. PubMed ID: 24504370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.